|
GAIN CONTROL OF YOUR INCONTINENCE |
Leaky Bladder
We now have What 15 Million Women have been waiting for...
ANNOUNCING THE AVAILABILITY OF A NEW, NON-INVASIVE, BREAKTHROUGH TREATMENT FOR URINARY LEAKAGE.
You cough. Laugh too hard. Or walk too far. And then it hits you. The loss of bladder control. If you're experiencing urinary leakage, you're not alone. It happens every day to an estimated 1.5 million women in this country. And contrary to popular belief. It is not a problem exclusively related to aging.
Joseph A Varallo,MD OB/GYN FACOG, in South Jersey is excited to offer NeoControl, the fastest breakthrough in incontinence treatment. This new FDA approved, non-surgical therapy is safe and effective for rebuilding strength and endurance in the pelvic floor muscles that control bladder flow. You simply sit fully clothed in a comfortable chair for treatment. It's completely non-invasive. No patches. No probes. No pain.
Call our South Jersey OB/GYN office today for a private consultation we will be glad to discuss solutions that could remedy your problem and help you regain your freedom.
NeoControl is a non-surgical, non-invasive therapy for the treatment of incontinence. No patches, no probes, no pain. For patients who suffer from incontinence caused by weakening of the pelvic floor muscles. Unlike any other therapy, NeoControl exercises all the muscles of the pelvic floor to rebuild strength and endurance, reestablishing bladder control.
The therapy is completely painless. Nothing other then the chair touches you. There are 16 treatments over the span of 8 weeks. The sessions last for 25 minutes. This is certainly better than the surgical option with all its potential risks.
With proper evaluation, which includes some in-office bladder testing and a thorough pelvic exam, most patients can be offered an alternative to surgery, provided there are no anatomic defects. My overall success rate in mild to moderate stress urinary incontinence has been 75%.
Read more about NeoControl here, or visit the official site here.